These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11830475)

  • 1. Functional in vivo characterization of human monoclonal anti-D in NOD-scid mice.
    Bazin R; Aubin E; Boyer L; St-Amour I; Roberge C; Lemieux R
    Blood; 2002 Feb; 99(4):1267-72. PubMed ID: 11830475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers.
    Kumpel BM; Goodrick MJ; Pamphilon DH; Fraser ID; Poole GD; Morse C; Standen GR; Chapman GE; Thomas DP; Anstee DJ
    Blood; 1995 Sep; 86(5):1701-9. PubMed ID: 7655002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of Rh D-positive red cells with monoclonal anti-D.
    Thomson A; Contreras M; Gorick B; Kumpel B; Chapman GE; Lane RS; Teesdale P; Hughes-Jones NC; Mollison PL
    Lancet; 1990 Nov; 336(8724):1147-50. PubMed ID: 1978026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions.
    Sibéril S; de Romeuf C; Bihoreau N; Fernandez N; Meterreau JL; Regenman A; Nony E; Gaucher C; Glacet A; Jorieux S; Klein P; Hogarth MP; Fridman WH; Bourel D; Béliard R; Teillaud JL
    Clin Immunol; 2006; 118(2-3):170-9. PubMed ID: 16332457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
    Kumpel BM
    Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies.
    Beliard R; Waegemans T; Notelet D; Massad L; Dhainaut F; Romeuf Cd; Guemas E; Haazen W; Bourel D; Teillaud JL; Prost JF
    Br J Haematol; 2008 Apr; 141(1):109-19. PubMed ID: 18279459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal anti-D development programme.
    Kumpel BM
    Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a competitive radioimmunoassay using monoclonal antibodies against Rh D for determining anti-D potency of clinical grade immunoglobulin preparations.
    Thorpe SJ; Heath AB
    Transfus Med; 1995 Jun; 5(2):97-103. PubMed ID: 7655583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
    Brinc D; Lazarus AH
    Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of producer cell line on functional activity of anti-D monoclonal antibodies destined for prevention of rhesus sensitization.
    Olovnikova NI; Ershler MA; Belkina EV; Nikolaeva TL; Miterev GY
    Bull Exp Biol Med; 2009 Apr; 147(4):448-52. PubMed ID: 19704946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the characteristics of human monoclonal and polyclonal anti-D as revealed by immunochemical investigations: human monoclonal antibodies share specificities with natural antibodies.
    Thorpe SJ; Bailey SW; Gooi HC; Thompson KM
    Transfus Med; 1992 Jun; 2(2):151-7. PubMed ID: 1284979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia.
    Zhang M; Zhang Z; Garmestani K; Goldman CK; Ravetch JV; Brechbiel MW; Carrasquillo JA; Waldmann TA
    Cancer Res; 2004 Aug; 64(16):5825-9. PubMed ID: 15313926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.
    Song S; Crow AR; Siragam V; Freedman J; Lazarus AH
    Blood; 2005 Feb; 105(4):1546-8. PubMed ID: 15479722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal anti-D for immunoprophylaxis.
    Scott ML
    Vox Sang; 2001 Nov; 81(4):213-8. PubMed ID: 11903995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
    Kumpel BM
    Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials.
    Béliard R
    Transfus Clin Biol; 2006; 13(1-2):58-64. PubMed ID: 16580863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic/pharmacodynamic model for the action of anti-D immunoglobulin in effecting circulatory clearance of Rh D+ red cells.
    Chapman GE
    Transfus Med; 1996 Sep; 6(3):227-33. PubMed ID: 8885152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodies.
    Chapman GE; Ballinger JR; Norton MJ; Parry-Jones DR; Beharry NA; Cousins C; Dash CH; Peters AM
    Clin Exp Immunol; 2007 Oct; 150(1):30-41. PubMed ID: 17680827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion.
    Oldham RJ; Mockridge CI; James S; Duriez PJ; Chan HTC; Cox KL; Pitic VA; Glennie MJ; Cragg MS
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies.
    Shulman IA; Calderon C; Nelson JM; Nakayama R
    Transfusion; 1994 Aug; 34(8):666-70. PubMed ID: 8073481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.